Emmecell

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction	Chandler syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Endothelial Cell Loss, Corneal Endothelial Dystrophy 1, Eye Diseases, Hereditary, Eye Manifestations, Fuchs' endothelial dystrophy, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, congenital hereditary endothelial dystrophy of cornea, corneal disorder, corneal dystrophy, corneal edema, eye disorder, hereditary disease	Recruiting	Phase 2	2026-10-09	NCT07729137
Study to Assess Safety and Tolerability of Multiple Doses of EO2002	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Dystrophy, Posterior Polymorphous, 1, Eye Diseases, Hereditary, Fuchs' endothelial dystrophy, bullous keratopathy, corneal disorder, corneal dystrophy, corneal edema, corneal endothelial dystrophy, eye disorder, hereditary disease	Recruiting	Phase 1	2025-12-08	NCT05636579
Safety and Tolerability of EO2002	Corneal Endothelial Cell Loss, Eye Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, cataract, corneal disorder, eye disorder, lens disorder	Recruiting	Phase 1	2025-12-08	NCT05587205

Clinical trials